India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
The SRV LHPL centre of excellence in robotic orthopaedics will be helmed by joint replacement surgeon, Dr Narendra Vaidya
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults
Technology Development Board supports commercialisation of Metal Injection Molding of implants
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
The fund will take equity positions in India-focused healthcare and life sciences-related companies
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Subscribe To Our Newsletter & Stay Updated
